http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006063158-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_029116ee41eeec8a03f88a8cddbaa758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ae3c8fd8ac89b71d5d64a32bf6524bd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
filingDate 2005-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc7e85c8b0829168572654256633f626
publicationDate 2006-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006063158-A3
titleOfInvention Use of supercritical fluids to incorporate biologically active agents into nanoporous medical articles
abstract The present invention is directed to a method in which a supercritical fluid that comprises a carrier fluid and a biologically active agent is brought into contact with medical article that comprises a nanoporous surface region. A variety of medical articles may be used in the practice of the present invention, including implantable or insertable medical devices such as bone plates, joint prostheses, vascular grafts, stent grafts, stents, catheters, guide wires, balloons, filters, vascular patches, shunts, and coils, among others. The nanoporous surface region may be, for example, metallic, ceramic, or polymeric in nature. Examples of biologically active agents include antirestenotic agents and agents that promote tissue adhesion, among others. Carbon dioxide is one of many carrier fluids that may be employed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9284409-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8920491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8932346-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8900292-B2
priorityDate 2004-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9418264-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003044514-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762

Total number of triples: 24.